Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Battella

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pancreas|January 27, 2015
Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic functionFrancesco Iannone, Alessandra Porzia, Giovanna Peruzzi, et al.
Oncoimmunology|May 8, 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patientsM Christina Cox, Simone Battella, Raffaella La Scaleia, et al.
Frontiers in Immunology|May 19, 2023
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signatureAmbra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Frontiers in Immunology|March 3, 2023
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signatureAmbra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Oncotarget|September 20, 2014
Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated CetuximabRita De Santis, Antonio Rosi, Anna Maria Anastasi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19Stefania Capone, Angelo Raggioli, Michela Gentile, et al.
Vaccines|February 26, 2026
Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory ApproachReji Paalangara, Stephanie Gohin, Alexis Menard, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pancreas|January 27, 2015
Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic functionFrancesco Iannone, Alessandra Porzia, Giovanna Peruzzi, et al.
Oncoimmunology|May 8, 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patientsM Christina Cox, Simone Battella, Raffaella La Scaleia, et al.
Frontiers in Immunology|May 19, 2023
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signatureAmbra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Frontiers in Immunology|March 3, 2023
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signatureAmbra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Oncotarget|September 20, 2014
Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated CetuximabRita De Santis, Antonio Rosi, Anna Maria Anastasi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19Stefania Capone, Angelo Raggioli, Michela Gentile, et al.
Vaccines|February 26, 2026
Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory ApproachReji Paalangara, Stephanie Gohin, Alexis Menard, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
Pageof 3